Medigene AG: Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells
– Synergies between the recombinant T cell technologies of Medigene and self-delivering RNAi technologies from RXi Pharmaceuticals will be explored preclinically – Research results could lead to the development of next generation recombinant T cells with improved characteristics for optimized Mehr